Cogent Biosciences, Inc. (COGT)

40.00 -0.17 (-0.42%) USD  |  NASDAQ  |  Dec 24, 10:47
More

Cogent Biosciences SG&A Expense (TTM): 51.34M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for COGT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Pfizer Inc. 13.91B
Ionis Pharmaceuticals, Inc. 351.68M
ADMA Biologics, Inc. 96.37M
Editas Medicine, Inc. 54.90M
AnaptysBio, Inc. 45.14M